Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Smartphone Based-PPG Assessment of REconversion in Persistent Atrial Fibrillation: a Randomized Controlled Trial

NCT07752940 is registered in ClinicalTrials.gov with Ziekenhuis Oost-Limburg as lead sponsor.

NCT NCT07752940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07752940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Smartphone Based-PPG Assessment of REconversion in Persistent Atrial Fibrillation: a Randomized Controlled Trial
Lead sponsor
Ziekenhuis Oost-Limburg
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
July 31, 2028
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af)